Literature DB >> 26341078

[Completely subcutaneous implantable cardioverter defibrillator: Care of S-ICD wearers during childbirth].

C Strewe1, S Fichtner2.   

Abstract

Inappropriate shock delivery is a problem that has been described for subcutaneous implantable cardioverter defibrillators (S-ICDs). Situations which predispose inappropriate shock delivery, such as childbirth, must be identified and the best treatment strategies selected. Inactivation of the S-ICD is the safest approach to avoiding inappropriate shock delivery. Inactivation of the S-ICD requires adequate patient monitoring and facilities for manual shock delivery.

Entities:  

Keywords:  Defibrillation; Monitoring; Parturition; Shock delivery; Sudden cardiac death

Mesh：

Year:  2015        PMID： 26341078     DOI： 10.1007/s00101-015-0082-y

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


  8 in total

1.  Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.

Authors:  Raul Weiss; Bradley P Knight; Michael R Gold; Angel R Leon; John M Herre; Margaret Hood; Mayer Rashtian; Mark Kremers; Ian Crozier; Kerry L Lee; Warren Smith; Martin C Burke
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

2.  [Current status and problems of the entirely subcutaneous ICD (S-ICD®)].

Authors:  F Reinke; A Löher; J Köbe; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-09

3.  Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.

Authors:  Louise R A Olde Nordkamp; Tom F Brouwer; Craig Barr; Dominic A M J Theuns; Lucas V A Boersma; Jens B Johansen; Petr Neuzil; Arthur A M Wilde; Nathan Carter; Michael Husby; Pier D Lambiase; Reinoud E Knops
Journal:  Int J Cardiol       Date:  2015-05-22       Impact factor: 4.164

4.  Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.

Authors:  Kirsten M Kooiman; Reinoud E Knops; Louise Olde Nordkamp; Arthur A M Wilde; Joris R de Groot
Journal:  Heart Rhythm       Date:  2013-12-07       Impact factor: 6.343

5.  Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

Authors:  Thomas Kleemann; Torsten Becker; Klaus Doenges; Margit Vater; Jochen Senges; Steffen Schneider; Werner Saggau; Udo Weisse; Karlheinz Seidl
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

6.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Authors:  Louise R A Olde Nordkamp; Lara Dabiri Abkenari; Lucas V A Boersma; Alexander H Maass; Joris R de Groot; Antonie J H H M van Oostrom; Dominic A M J Theuns; Luc J L M Jordaens; Arthur A M Wilde; Reinoud E Knops
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

7.  Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.

Authors:  Lara Dabiri Abkenari; Dominic A M J Theuns; Suzanne D A Valk; Yves Van Belle; Natasja M de Groot; David Haitsma; Agnes Muskens-Heemskerk; Tamas Szili-Torok; Luc Jordaens
Journal:  Clin Res Cardiol       Date:  2011-03-17       Impact factor: 5.460

8.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Authors:  Pier D Lambiase; Craig Barr; Dominic A M J Theuns; Reinoud Knops; Petr Neuzil; Jens Brock Johansen; Margaret Hood; Susanne Pedersen; Stefan Kääb; Francis Murgatroyd; Helen L Reeve; Nathan Carter; Lucas Boersma
Journal:  Eur Heart J       Date:  2014-03-26       Impact factor: 29.983
  8 in total
  1 in total

Review 1.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.